Fax: (713) 563-2331
Version of Record online: 22 MAR 2011
Copyright © 2011 American Cancer Society
Volume 117, Issue 20, pages 4707–4713, 15 October 2011
How to Cite
Chang, J. Y., Komaki, R., Lu, C., Wen, H. Y., Allen, P. K., Tsao, A., Gillin, M., Mohan, R. and Cox, J. D. (2011), Phase 2 study of high-dose proton therapy with concurrent chemotherapy for unresectable stage III nonsmall cell lung cancer. Cancer, 117: 4707–4713. doi: 10.1002/cncr.26080
Portions of this work were presented at the 2009 annual meeting of the American Society of Radiation Oncology, Chicago, Illinois, November 1-5, 2009 and published in abstract form (Int J Radiat Oncol Biol Phys. 2009;75:S446).
We thank the Thoracic Radiation Oncology and Proton Therapy Center teams at The University of Texas MD Anderson Cancer Center for their help and support and Ms. Christine Wogan of the Division of Radiation Oncology at The University of Texas MD Anderson Cancer Center for editorial assistance.
- Issue online: 5 OCT 2011
- Version of Record online: 22 MAR 2011
- Manuscript Accepted: 21 JAN 2011
- Manuscript Revised: 18 JAN 2011
- Manuscript Received: 15 DEC 2010
- 2Long term benefit is observed in a phase III comparison of sequential vs concurrent chemo-radiation for patients with unresectable NSCLC: RTOG 9410 [abstract]. Proc Am Soc Clin Oncol. 2003; 22:621a., , , et al.
- 4Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique-Groupe Francais de Pneumo-Cancerologie NPC 95-01 study. J Clin Oncol. 2005; 23: 5910-5917., , , et al.
- 7Primary analysis of the phase II component of a phase I/II dose intensification study using 3-dimensional conformal radiation therapy and concurrent chemotherapy for patients with inoperable non-small-cell lung cancer: RTOG 0117. J Clin Oncol. 2010; 28: 2475-2480., , , et al.
- 13Toxicity and patterns of failure of adaptive/ablative proton therapy for early stage medically inoperable non-small cell lung cancer. Int J Radiat Oncol Biol Phys. [published online ahead of print January 18, 2011.], , , et al.
- 15Proton beam therapy of stage II and III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. [published online ahead of print September 30, 2010.], , , et al.
- 16Proton radiation therapy for lung cancer: is there enough evidence? Oncology. 2010; 24: 1052-1057..
- 20Intensity-modulated proton therapy reduces normal tissue doses compared with intensity-modulated radiation therapy or passive scattering proton therapy and enables individualized radical radiotherapy for extensive stage IIIB-non-small cell lung cancer: a virtual clinical study. Int J Radiat Oncol Biol Phys. 2010; 77: 357-366., , , et al.